-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca shares fell 7.3% after reports said the company had preliminary negotiations with Bristol-Myers Squibb over a possible merger.

Zhitongcaijing·08/03/2026 07:09:02
Listen to the news
AstraZeneca shares fell 7.3% after reports said the company had preliminary negotiations with Bristol-Myers Squibb over a possible merger.